Skip to main content
logo
BriaCell Therapeutics Corp. (TSX:BCT)
Canada flag Canada · Delayed Price · Currency is CAD
5.40
-0.17 (-3.05%)
Nov 9, 2026, 1:00 PM EST

BriaCell Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Aug - Jul.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Market Capitalization
47421819140130
Market Cap Growth
75.78%136.55%-5.88%-86.55%7.66%32.65%
Enterprise Value
1710-01710273
Last Close Price
5.574.8210.10154.501314.001257.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
PB Ratio
2.231.920.74-5.08-28.189.82
P/TBV Ratio
2.141.840.72--10.05

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Net Debt / Equity Ratio
-1.32-1.32-1.030.325.63-3.97
Net Debt / EBITDA Ratio
0.570.570.660.030.912.69
Net Debt / FCF Ratio
0.710.710.630.040.903.29
Quick Ratio
2.762.764.490.2111.8043.64
Current Ratio
2.762.765.010.4914.9645.00
Return on Equity (ROE)
-214.79%-214.79%-362.56%--619.75%-141.25%
Return on Assets (ROA)
-99.64%-99.64%-123.56%-126.11%-41.71%-18.99%
Return on Capital Employed (ROCE)
-231.10%-231.10%-153.90%2097.70%-91.80%-36.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jul '26 Jul '25 Jul '24 Jul '23 Jul '22
Earnings Yield
-181.07%-116.77%-205.42%-35.14%-19.08%-26.45%
FCF Yield
-83.00%-96.28%-219.93%-180.31%-22.31%-12.30%
Buyback Yield / Dilution
-1084.29%-1084.29%-285.70%-5.35%-0.81%-242.82%